Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery

Withdrawn before enrolling · Phase 2

Conditions studied: Anorectal Surgeries

In brief

EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).

Key facts

Study ID

NCT02617706

Run by

Neogenix, LLC dba Ogenix

People needed

0

Starts

2017-01-01

Expected to finish

2019-01-01

Last updated by the study team

2017-08-14

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Elective colo-rectal surgery with or without anastomosis and with or without stoma
• Patient age: 18-80

You may not qualify if…

• Pregnancy
• Anesthesiology ASA score of 4 or above
• fever or existing signs of infection at the time of surgery
• Diabetes Mellitus type I or II with HbA1C level 12% or more
• Persons with decubitus or diabetic ulcers
• Subjects with peritoneal metastases
• Patients with severe malnutrition as indicated by Prealbumin value of <20
• BMI ≥50

Where it is running

• Department of General Surgery Allegheny General Hospital — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.